Presentation | November 24, 2025

Flexible And Scalable Capacity That Grows With You

Source: medac CDMO
GettyImages-1220710526 lab, research

medac CDMO offers a strategic partnership for aseptic fill/finish manufacturing, leveraging over 25 years of expertise and proven global compliance. The company provides flexible and scalable capacity, supporting global pharma needs from early clinical supply through to large-scale commercial manufacturing.

Manufacturing facilities in Dessau, Germany, and Brno, Czech Republic, offer solutions for various dosage forms, including vials (high-potent, non-potent, biologics, ADCs) and pre-filled syringes, with cartridges planned for 2026. Formulations handled include liquid, liquid terminally sterilized, and freeze-dried. The service scope encompasses small molecules, high-potency compounds (OEL <10 ng/m3), large molecules (biologics), oligonucleotides, and Antibody-Drug Conjugates (ADCs). Furthermore, the company provides development support, clinical and commercial supply, global regulatory assistance, and comprehensive analytical/microbiological laboratory services.

Discover the full capabilities and line-specific details of these end-to-end CDMO services.

access the Presentation!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online